Pure Global AI
Disease / condition

Sickle Cell Disease clinical trials

Free access to 424 studies10+ countriesUpdated daily111 recruiting
VerifiedClinicalTrials.gov · WHO ICTRP · regional registries
424
Total trials
10+
Countries
10+
Sponsors
111
Recruiting
By phase
N/A225
Phase 265
Phase 148
Phase 330
Early Phase 129
By status
Completed172
Recruiting111
Not yet recruit...40
Terminated31
Unknown30
Top countries
United States of America227
France30
Belgium10
United Kingdom9
Netherlands7
Top sponsors
St. Jude Children'...21
Emory University19
Assistance Publiqu...17
Global Blood Thera...13
National Heart, Lu...11
Recent trials
Latest clinical trials for Sickle Cell Disease
School Readiness Intervention for Preschool Children With Sickle Cell Disease
St. Jude Children's Research H... · United States of America
NCT06367192Recruiting
Comparative Health Status and Quality of Life of Patients With Sickle Cell Disease (SCD) Who Underwent Matched-sibling Hematopoietic Stem Cell Transplantation Versus Non Transplanted SCD Case-control Patients
Assistance Publique - Hôpitaux...
NCT06351462Not yet recr...
Sickle Cell Disease Transplant Using a Nonmyeloablative Approach for Patients With Anti-donor Red Cell AntibodY
Children's National Research I... · United States of America
NCT06358638Recruiting
Phase
Phase 2
Uganda Sickle Surveillance Study (US-3)
Children's Hospital Medical Ce... · Uganda
NCT06301893Recruiting
Clinical Study of BRL-101 in Severe SCD
Bioray Laboratories · China
NCT06300723Not yet recr...
Patient and Public Involvement and Engagement in Research With Children and Young People With Sickle Cell Disorder and Their Families
King's College London · United Kingdom
NCT06293222Recruitment ...
Clinical Study on the Safety and Efficacy of BRL-101 in the Treatment of Sickle Cell Disease
Bioray Laboratories
NCT06287086Not yet recr...
Clinical Study of BRL-101 in the Treatment of Sickle Cell Disease
Bioray Laboratories
NCT06287099Not yet recr...
mAnaging siCkle CELl disEase Through incReased AdopTion of hydroxyurEa in Nigeria
New York University
NCT06318143Not yet recr...
Zinc Supplementation in Sickle Cell Disease
University of California, San ... · United States of America
NCT06260891Not yet recr...
Phase
Phase 2
Support Strategies for Parents During the First Year Following Their Child's Diagnosis of Sickle Cell Disorder
King's College London
NCT06251843Not yet recr...
Applying Directly Observed Therapy to Hydroxyurea to Realize Effectiveness
Nationwide Children's Hospital · United States of America
NCT06264700Not yet recr...
The Role of Endothelin 1 as a Marker of Renal Impairment in Sickle Cell Disease
Sohag University · Egypt
NCT06158945Recruiting
Long-term Follow-up (LTFU) of Patients Treated With Genome-edited Autologous Hematopoietic Stem and Progenitor Cells (HSPC)
Novartis Pharmaceuticals
NCT06155500Not yet recr...
Non-myeloablative Haploidentical HCT Study for Patients With Sickle Cell Disease, Including Compromised Organ Function
National Heart, Lung, and Bloo... · United States of America
NCT06145282Not yet recr...
Phase
Phase 1/2
Development and Adaptation of I-STRONG for SCD
Emory University · United States of America
NCT06110754Recruiting
Sickle Cell Children's Exercise Study (SuCCESs)
University of Maryland, Baltim...
NCT06074198Not yet recr...
SMYLS Multi-site Trial
Medical University of South Ca... · United States of America
NCT06035939Not yet recr...
Assessing Physical Function in Sickle Cell Patients Taking Voxelotor
Inova Health Care Services · United States of America
NCT06023199Recruiting
A Phase 2 Open-label Study to Evaluate the Activity of Etavopivat on Transcranial Doppler Velocities in Pediatric Patients With Sickle Cell Disease Who Are at Increased Risk for Primary Stroke
Novo Nordisk A/S · India,Nigeria,Oman
NCT05953584Recruiting
Phase
Phase 2
About this profile

Access comprehensive clinical trial information for Sickle Cell Disease through Pure Global AI's free database. This collection includes 424 clinical trials across multiple phases including N/A, Phase 2, Phase 1. Currently, 111 trials are actively recruiting participants.

Research for Sickle Cell Disease is being conducted in United States of America, France, Belgium and 7+ other countries. Leading sponsors include St. Jude Children's Research Hospital and Emory University. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 424 clinical trials studying Sickle Cell Disease, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include St. Jude Children's Research Hospital, Emory University, Assistance Publique - Hôpitaux de Paris, among others.